Literature DB >> 16200651

Characterization of a new methylated Beta-cyclodextrin with a low degree of substitution by electrospray ionization mass spectrometry and liquid chromatography/mass spectrometry.

Romain Jacquet1, Claire Elfakir, Michel Lafosse.   

Abstract

A new methylated beta-cyclodextrin (Me-beta-CD) with a low degree of substitution (DS) was characterized by electrospray ionization mass spectrometry (ESI-MS) and liquid chromatography coupled with ESI-MS (LC/ESI-MS). For ESI-MS analyses, the composition of the infused sample solution was optimized in order to obtain only singly charged ammoniated CDs without fragmentation. The DS value (i.e. the number of methyl groups per glucopyranose unit) was found to be 0.7, which was in accordance with the values previously obtained by other methods. The LC/ESI-MS analysis, derived from a method using evaporative light scattering detection, allowed the study of the substitution isomers of each derivative and appears to be an easy and rapid tool for the accurate characterization of Me-beta-CD mixtures. (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200651     DOI: 10.1002/rcm.2175

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  3 in total

1.  A novel solid dosage form of rifampicin and isoniazid with improved functionality.

Authors:  Mukesh C Gohel; Krishnakant G Sarvaiya
Journal:  AAPS PharmSciTech       Date:  2007-08-24       Impact factor: 3.246

2.  Tandem Electrospray Mass Spectrometry of Cyclic N-Substituted Oligo-β-(1→6)-D-glucosamines.

Authors:  Alexander O Chizhov; Marina L Gening; Yury E Tsvetkov; Nikolay E Nifantiev
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

3.  Structural Architectural Features of Cyclodextrin Oligoesters Revealed by Fragmentation Mass Spectrometry Analysis.

Authors:  Cristian Peptu; Maksym Danchenko; Ľudovít Škultéty; Jaroslav Mosnáček
Journal:  Molecules       Date:  2018-09-05       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.